Quoting IMS MAT September 2016 data, Lupin said, Paxil CR tablets had US sales of $127.7 million.
The transaction will be EPS (earnings per share) accretive, Zydus Cadila said in a statement.
The additional sum is derived on the basis of the value of mutual funds, cash and bank balance, tax refunds etc at the time of closing, it added.
Balaji Srinivasan met Trump at the Trump Towers in New York on Thursday. No official announcement has been made yet.
Drug firm Cadila Healthcare has settled all outstanding patent litigation related to Livalo tablets with Kowa Company, Kowa Pharmaceuticals America Inc and Nissan Chemical Industries Ltd.
Citing IMS MAT September 2016 data, the company said MS Contin ER tablets had sales of USD 282.9 million in the US market.
US President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder".
Last year, the USFDA had put the company's Ratlam-based active pharmaceutical ingredients(API) facility under import alert.
Lankau has over 30 years of management experience in developing and commercialising pharmaceutical products.
Last month, the US regulator had made five observations after inspection of the company's manufacturing plant at Visakhapatnam.
Aurobindo Pharma on Saturday said it has inked a binding agreement, through its wholly-owned subsidiary Agile Pharma BV Netherlands, to acquire Generis Farmaceutica SA from Magnum Capital Partners for a total consideration of 135 million euros.
Natco and Breckenridge filed their ANDA with a Paragraph IV certification on the first-to-file date and expect to share 180-day exclusivity with other ANDA first filers,
USFDA has already banned import of products from the facility into the US market since August 5, 2016.
At day's high, Jubilant Life Sciences shares recorded gains of more than 13 per cent in two trading sessions.
The company's current portfolio consists of 112 products authorised for distribution in the US marketplace and 63 ANDA pending approval with the US regulator.
Olmesartan Medoximil tablets, a generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents to lower blood pressure, it added.
The National Drug Pricing Regulator has also fixed the retail prices of 29 formulations.